Syspiro Diagnostics develops a unique system for monitoring fetal health during delivery. The purpose is to ensure that the fetus does not suffer from oxygen depletion. Syspiro Diagnostics’ system consists of a disposable device and an analysis unit. The system will provide the nursing staff with continuous and specific information about the fetal health. The information obtained is more reliable than the information from existing systems today, which will improve the monitoring process and in turn reduce the risks for the mother and the fetus.
Syspiro Diagnostics
Syspiro Diagnostics Stories
There are currently no stories published about this venture.
Syspiro Diagnostics develops a unique system for monitoring fetal health during delivery.
Johanna Lundstedt, CEO
Syspiro Diagnostics is an Encubator Portfolio Company from GIBBS class of 2007.
Syspiro Diagnostics develops a unique system for monitoring fetal health during delivery.
Medtech
Jan Söderlund
Carina Mallard
Henrik Hagberg
+46 31-788 00 79
Holtermansgatan 1C, Gothenburg
